Receive updates from Patient Advocates and MS specialists sent directly to your inbox.

Sign up now


Teva's Shared Solutions® believes that no one should have to switch or discontinue RMS therapy because of financial reasons. Teva's Shared Solutions® is committed to helping you find affordable access to COPAXONE®.

Call 1-800-887-8100 now for answers to financial questions about COPAXONE®:

COPAXONE Co-Pay Solutions®

With COPAXONE Co-Pay Solutions®, commercially insured patients taking 3-times-a-week COPAXONE® 40 mg may lower their monthly out of pocket costs to $0.†† Terms and conditions apply. Have your insurance card, prescription card and income information available when completing the Benefits Discussion Guide, then call Teva's Shared Solutions® at 1-800-887-8100 to see if you’re eligible:

  • No financial qualifications and no paperwork are required.

  • Patients with a new or recently changed commercial prescription may be eligible.

  • More than 70% of COPAXONE® patients pay less than $10 per month out of pocket.

  • Receive a co-pay card for COPAXONE® to use when filling your prescription or refills, based on applicable private/state/federal programs.

Call 1-800-887-8100 now for answers to financial questions about COPAXONE®:

  • What if my insurance co-pay changes?

    For 3-times-a-week COPAXONE® 40 mg, you may be able to lower your out-of-pocket costs to $0 per month†† with COPAXONE Co-Pay Solutions®. For daily COPAXONE® 20 mg, Teva’s Shared Solutions® may be able to help lower your co-pay. Terms and Conditions apply.

  • What if I don’t have insurance?

    The Benefits Specialists at Teva’s Shared Solutions® will work with you to help you find affordable access to COPAXONE®, although lower-cost options are not guaranteed.

  • What does glatiramer acetate injection cost?

    Contact your pharmacy for actual out-of-pocket costs for your prescription.

  • Are generic options of COPAXONE® more affordable?1

    Contact your pharmacy for actual out-of-pocket costs for your prescription.

  • Is COPAXONE® covered by Medicare?

    Teva’s Shared Solutions® will customize an evaluation of Medicare Part D plans in order to recommend the best coverage for COPAXONE®, as well as any other medications you may be taking. If needed, the team can also provide information about third-party financial assistance programs.

Finding affordable access to COPAXONE® may be easier than you think.

With Teva's Shared Solutions®, a dedicated team is available to research your coverage and insurance benefits, for personalized financial assistance that may save you time and money out of your pocket. Teva Benefits Specialists will:

  • Investigate insurance benefits, to see if your plan covers Teva's COPAXONE®.

  • Research pharmacy benefits, to help determine the most convenient way for you to receive Teva's COPAXONE®.

  • Contact your insurance provider on your behalf and investigate insurance options available to you.

  • Assist with understanding insurance benefits, any changes that can affect coverage, how to choose or change plans, and how to navigate Medicare Part D.


COPAXONE® (glatiramer acetate injection) is prescription medicine used for the treatment of people with relapsing forms of multiple sclerosis (MS).

Important Safety Information

Do not take COPAXONE® if you are allergic to glatiramer acetate or mannitol.

Some patients report a short-term reaction right after or within minutes after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain, fast heart beat, anxiety, and trouble breathing. These symptoms generally appear within seconds to minutes of an injection, last about 15 minutes, and do not require specific treatment. During the postmarketing period, there have been reports of patients with similar symptoms who received emergency medical care. If symptoms become severe, call the emergency phone number in your area. Call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, or severe pain at the injection site. If any of the above occurs, do not give yourself any more injections until your doctor tells you to begin again.

Chest pain may occur either as part of the immediate post-injection reaction or on its own. This pain should only last a few minutes. You may experience more than one such episode, usually beginning at least one month after starting treatment. Tell your doctor if you experience chest pain that lasts for a long time or feels very intense.

A permanent indentation under the skin (lipoatrophy or, rarely, necrosis) at the injection site may occur, due to local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

The most common side effects of COPAXONE® include redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These are not all of the possible side effects of COPAXONE®. For a complete list, ask your doctor or pharmacist. Tell your doctor about any side effects you have while taking COPAXONE®.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.

Please see full Prescribing Information for Teva's COPAXONE®.

Reference: 1. IQVIA Health National Prescription Audit, September 2018. Data proprietary to IQVIA.

Injections for 3-times-a-week COPAXONE® 40 mg must be at least 48 hours apart.

autoject®2 for glass syringe is a registered trademark of Owen Mumford, Ltd. Available by prescription only.
Apple is a registered trademark of Apple Inc. App Store is a service mark of Apple Inc.
Google Play and the Google Play logo are trademarks of Google LLC.

You are about to leave and enter a website operated by a third party.

Would you like to continue?

The information on this site is intended for healthcare professionals in the United States. Are you a healthcare professional in the United States?